Showing results (151-160 of 169) with videos related to
Sort By:
Pageof 17
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2007
LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximabYasodha Natkunam, Pedro Farinha, Eric D Hsi, et al.Oncoimmunology|September 14, 2016
Immunomodulatory antibodies for the treatment of lymphoma: Report on the CALYM WorkshopRoch Houot, Philippe Gaulard, Robert Schreiber, et al.Blood|June 15, 2011
Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironmentAsh A Alizadeh, Andrew J Gentles, Alvaro J Alencar, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2016
Results from an Integrated Safety Analysis of Urelumab, an Agonist Anti-CD137 Monoclonal AntibodyNeil H Segal, Theodore F Logan, F Stephen Hodi, et al.Blood Cancer Discovery|January 11, 2022
CD20-Targeted Therapy Ablates De Novo Antibody Response to Vaccination but Spares Preestablished ImmunityTanaya Shree, Vishnu Shankar, Julian J K Lohmeyer, et al.Journal of the American Chemical Society|October 21, 2025
<i>In Vivo</i> mRNA Delivery to the Lung Vascular Endothelium by Dicationic Charge-Altering Releasable TransportersMahmoud M AbdElwakil, Jeffrey Ni, Summer Ramsay-Burrough, et al.Cell Stem Cell|February 20, 2018
Autologous iPSC-Based Vaccines Elicit Anti-tumor Responses In VivoNigel G Kooreman, Youngkyun Kim, Patricia E de Almeida, et al.Cell|September 4, 2010
Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphomaMark P Chao, Ash A Alizadeh, Chad Tang, et al.The Journal of Clinical Investigation|May 20, 2014
Targeting CD137 enhances the efficacy of cetuximabHolbrook E Kohrt, A Dimitrios Colevas, Roch Houot, et al.International Journal of Molecular Epidemiology and Genetics|September 15, 2011
Immunostaining to identify molecular subtypes of diffuse large B-cell lymphoma in a population-based epidemiologic study in the pre-rituximab eraLindsay M Morton, James R Cerhan, Patricia Hartge, et al.Pageof 17